arrow_back Back to App

Securing US Borders Against Fentanyl: New Technologies and Reports.

This act aims to enhance citizen safety by strengthening US border controls to detect and stop illegal fentanyl. It involves investing in new technologies and improving data collection, which should reduce the availability of this dangerous substance in the country. As a result, citizens may experience improved public safety and health.
Key points
Introduction of new technologies to detect fentanyl and its precursors at borders, including in counterfeit pills.
Establishment of a program to collect data and measure the effectiveness of current drug interdiction methods.
Requirement for regular reports to Congress on the effectiveness of technologies and strategies, including cost-benefit analyses.
Improvement of the drug control strategy evaluation system, including at borders, to better tailor actions to regional specifics.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_5052
Sponsor: Sen. Kelly, Mark [D-AZ]
Process start date: 2022-09-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing America’s Borders Against Fentanyl Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_5052.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-09-29.

What are the main provisions?

Key points include:

  • Introduction of new technologies to detect fentanyl and its precursors at borders, including in counterfeit pills.
  • Establishment of a program to collect data and measure the effectiveness of current drug interdiction methods.
  • Requirement for regular reports to Congress on the effectiveness of technologies and strategies, including cost-benefit analyses.
  • Improvement of the drug control strategy evaluation system, including at borders, to better tailor actions to regional specifics.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kelly, Mark [D-AZ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Security Health